Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026 Read more
Clinical Trials Support Service Market to Reach US$ 47.1 Billion by 2032 Driven by Rising Trial Complexity, Patient-Centric Models, and AI-Based Trial Management | Astute Analytica Read more
D-dimer Testing Market to Reach US$ 2,269.31 Million by 2032 Supported by Growing Thromboembolic Disease Burden and Expansion of Point-of-Care Diagnostics Says Astute Analytica Read more
In-Vitro Toxicology Testing Market to Reach US$ 57.55 Billion by 2033 Supported by OECD Guidelines, EPA NAM Framework, and EU Cosmetics Regulation Says Astute Analytica Read more